Ovarian Function, Not Age, Predicts the Benefit from Ovarian Suppression or Ablation for Premenopausal Women with Breast Cancer

The role of adjuvant ovarian suppression or ablation (OS/OA) in premenopausal women with hormone receptor-positive breast cancer remains controversial. The purpose of our study was to examine which patients might benefit from the addition of OS/OA to tamoxifen. We analyzed the data of 2065 premenopa...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Cong, Peng, Roujun, Cao, Ye, Wang, Shusen, Shi, Yanxia, An, Xin, Xu, Fei, Yuan, Zhongyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750981/
https://www.ncbi.nlm.nih.gov/pubmed/26866810
http://dx.doi.org/10.1371/journal.pone.0148849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750981/
https://www.ncbi.nlm.nih.gov/pubmed/26866810
http://dx.doi.org/10.1371/journal.pone.0148849

Ejemplares similares